Prana Therapies
Prana Therapies, Inc.
Clinical-stage biotechnology company pioneering multispecific antibodies via INSPIRE platform. Advancing PRA-216 for respiratory & dermatologic diseases.
pranatherapies.com · Encinitas, CA
Funding event
The round itself, as filedInferred stageSeries B
Sold of offered$40.2M of $40.2M
Filed2026-08-10
Days since filing55
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2025-11-25
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Ben AuspitzDirector
- Alexis BorisyDirector
- Sheila Gujrathi, M.D.Executive Officer · Director
- Hector OrtegaExecutive Officer
- Ryan SullivanExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged100% sold10.3 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-230
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.